Back to SUPN
Hennion & Walsh Asset Management, Inc. → SUPN
Hennion & Walsh Asset Management, Inc. SUPN Position History
Supernus Pharmaceuticals, Inc. • Healthcare
Quarters held
5
Latest value
$3.9M
Q3 2026
Peak value
$4.9M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $4.9M |
| Q4 2025 | $4M |
| Q1 2026 | $4.6M |
| Q2 2026 | $4.2M |
| Q3 2026 | $3.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.9M | 90.2K | — | — |
| Q2 2026 | $4.2M | 90.2K | — | — |
| Q1 2026 | $4.6M | 88.5K | — | — |
| Q4 2025 | $4M | 80.7K | — | — |
| Q3 2025 | $4.9M | 101.7K | — | — |
Other funds holding SUPN
$179.2M
$171.4M
$164.2M
$118.3M
$114.4M
$114.4M